Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-05 Purchase | 2021-02-09 7:56 pm | Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner | 250,187 | $12.84 | $3,212,446 | 14,869,915 (Indirect) | View |
| 2021-02-08 Purchase | 2021-02-08 6:08 pm | Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner | 1,250,000 | $16 | $20,000,000 | 14,619,728 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-14 4:10 pm | N/A 2034-06-12 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-20 5:27 pm | N/A N/A | LianBio | LIAN | Poukalov Konstantin Director | 19,218 | $4.76 | 17,082 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 5:27 pm | 2023-06-23 2032-06-23 | LianBio | LIAN | Poukalov Konstantin Director | 36,300 | $0 | 17,082 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 5:27 pm | N/A N/A | LianBio | LIAN | Poukalov Konstantin Director | 36,300 | $2.52 | 17,082 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:50 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:10 pm | N/A 2033-06-21 | LianBio | LIAN | Poukalov Konstantin Director | 36,300 | $0 | 36,300 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:37 pm | N/A 2032-06-23 | LianBio | LIAN | Poukalov Konstantin Director | 36,300 | $0 | 36,300 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 7,250 | $0 | 7,250 (Direct) | View |
Ownership | 2021-10-29 6:36 pm | N/A 2030-12-17 | LianBio | LIAN | Poukalov Konstantin Director | 0 | $0 | 146,195 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:25 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-02-08 Conversion | 2021-02-08 6:08 pm | N/A N/A | Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner | 26,739,456 | $0 | 14,619,728 (Indirect) | View |
Ownership | 2021-02-03 6:29 pm | N/A N/A | Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner | 0 | $0 | 13,369,728 (Indirect) | View |
| 2020-04-30 Option Award | 2020-05-01 6:38 pm | N/A 2030-04-29 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 14,500 | $0 | 14,500 (Direct) | View |